Targeted Temperature Management at 36°C after In-Hospital Cardiac Arrest Trial (TTM-36 IHCA Trial): Study Protocol for an Investigator-Initiated, Single-Center, Randomized, Controlled, Assessor-Blinded, Pilot Clinical Trial
Journal of Neurocritical Care. 2016;9(1):7-15 
Improving Use of Targeted Temperature Management After Out-of-Hospital Cardiac Arrest: A Stepped Wedge Cluster Randomized Controlled Trial
The Journal of Emergency Medicine. 2015;49(2):258
A pilot feasibility, safety and biological efficacy multicentre trial of therapeutic hypercapnia after cardiac arrest: study protocol for a randomized controlled trial
Trials. 2015;16(1):
Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response after Out-of-Hospital Cardiac Arrest (IMICA): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial
Trials. 2020;21(1):
Neurological prognostication after cardiac arrest and targeted temperature management 33°C versus 36°C: Results from a randomised controlled clinical trial
Resuscitation. 2015;93:164-170
The association of targeted temperature management at 33 and 36 °C with outcome in patients with moderate shock on admission after out-of-hospital cardiac arrest: a post hoc analysis of the Target Temperature Management trial
Intensive Care Medicine. 2014;40(9):1210-1219
Laparoscopic versus open distal pancreatectomy (LAPOP), study protocol for a single center, non-blinded randomized controlled trial
. 2018;
Laparoscopic versus open distal pancreatectomy (LAPOP), study protocol for a single center, non-blinded randomized controlled trial
. 2019;
Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response after Out-of-Hospital Cardiac Arrest (IMICA): study protocol for a randomized clinical trial
. 2019;
Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial)
Circulation. 2021;143(19):1841-1851